Does adding AI polyp detection to an existing scope need its own clearance?

Yes in most cases. A computer-aided detection function has its own intended use, its own performance claims and its own clinical evidence expectations, so FDA treats it as a distinct device (typically a de novo or 510(k) referencing a CADe predicate) rather than a feature of the endoscope platform.

What validation does reusable endoscope reprocessing actually require?

FDA's reprocessing guidance expects worst-case soiling with clinically relevant organic and microbial challenges, testing at the end of the labeled maximum reuse life, validated cleaning and high-level disinfection or sterilization steps, and human factors evidence that the instructions can be followed in a real reprocessing suite. Simulated-use testing on a single clean cycle is not sufficient.

All terms

Market SegmentsStrategic Landscape

Endoscopy Devices

Flexible and rigid scopes plus accessories used for visualization, diagnosis, and therapy inside the GI tract, airways, urinary tract, and joints.

Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 9, 2026

Definition

The endoscopy segment covers flexible video gastroscopes, colonoscopes, duodenoscopes, bronchoscopes, ureteroscopes, and rigid arthroscopes, together with the light sources, processors, capnography, insufflators, and single-use accessories (snares, biopsy forceps, hemoclips) that complete a procedure. The market splits between reusable scopes (capital + reprocessing) and a fast-growing single-use segment driven by infection-control concerns following duodenoscope-associated CRE outbreaks (FDA 2015-2019 safety communications).

What the regulation says

Most flexible endoscopes are Class II 510(k) devices under 21 CFR 876 (gastroenterology-urology) or 874 (ENT). FDA's reprocessing guidance and the duodenoscope safety communications materially changed expectations for reprocessing validation, single-use components (caps, elevators), and post-market surveillance studies (522 orders).

What this means in practice

Single-use scopes (Ambu, Boston Scientific Exalt) and disposable elevator caps reset the segment's economics. AI-assisted polyp detection (CADe) is now a major sub-segment with multiple FDA-cleared products (e.g., GI Genius, Endoscreener).

Examples

A gastroenterologist uses a flexible video colonoscope, connected to a light source and processor, to examine a patient's large intestine for polyps, utilizing single-use biopsy forceps to collect tissue samples for pathology.
During a minimally invasive orthopedic procedure, an arthroscope provides visual access to a patient's knee joint, allowing the surgeon to assess damage and perform repairs using specialized instruments inserted through accessory ports.
A pulmonologist employs a bronchoscope to visualize a patient's airways, assisting in the diagnosis of lung conditions while an insufflator maintains optimal working space for clear imaging and therapeutic interventions.

Common pitfalls

•Underestimating reprocessing validation requirements, FDA expects multi-cycle worst-case soiling validation.
•Treating an AI overlay as a feature rather than a separate SaMD requiring its own clearance.
•Ignoring FDA 522 post-market surveillance orders applicable to duodenoscopes.

Frequently asked questions

Repeated CRE and other multidrug-resistant infection outbreaks tied to incomplete reprocessing of the elevator mechanism led FDA to recommend transition to disposable-component or fully single-use designs in 2019.

Grouped by theme

Editor's picks

· Hand-selected related concepts

Market Segments

Single-Use Device(SUD)

A device the original manufacturer labels for one use or one patient, distinct from reusable devices and from FDA-regulated reprocessed SUDs.

Regulatory

510(k) Premarket Notification(510(k))

FDA submission demonstrating a device is substantially equivalent to a legally marketed predicate.

Post-Market

Post-Market Surveillance(PMS)

Activities to monitor device safety and performance after market release.

Software & AI

Software as a Medical Device(SaMD)

Software intended for medical purposes that performs without being part of a hardware device.

Latest in MedTech

Sources

3 sources

Sources support the definition or relevant regulatory context, not necessarily every claim on this page. Each is graded against our source-tier hierarchy so you can see what rests on binding law versus commentary.

Tier 1Binding law and standards· 1Tier 2Regulator guidance and consensus· 1Tier 4Trade press and expert commentary· 1

Link health: 3 verified· last checked 2026-06-20

FDA·1eCFR·1MedTech Dive·1

Inline markers like [1] jump to the matching reference above.

My progress

All terms0 / 513

Market Segments0 / 38

Saved on this device, and to your account when signed in. View studied terms

Full glossary

Browse all terms A to Z, each with a short definition.

On this term

Category: Market Segments
Sources: 3
Updated: 5/9/2026

Compare with another term

Learn in 60 seconds

Flexible and rigid scopes plus accessories used for visualization, diagnosis, and therapy inside the GI tract, airways, urinary tract, and joints.

·Single-use scopes (Ambu, Boston Scientific Exalt) and disposable elevator caps reset the segment's economics.
·AI-assisted polyp detection (CADe) is now a major sub-segment with multiple FDA-cleared products (e.g., GI Genius, Endoscreener).

Remember this

Watch out: Underestimating reprocessing validation requirements, FDA expects multi-cycle worst-case soiling validation.

Related terms

You may also need

Auto-suggested from Market Segments and shared keywords.

All Market Segments terms